Drug & Device Safety Atlas

FDA recall record · openFDA

Hikma Pharmaceuticals USA INC

5 FDA recalls on record (2023–2026) — 5 drug. 4 still ongoing.

1
Class I (most serious)
4
Class II
0
Class III
4
ongoing

How to read this. A recall count is not a quality verdict — large manufacturers recall more simply by volume, and a voluntary recall is the safety system working as intended. The signal to weight is the Class I count (the FDA's most-serious tier — reasonable probability of serious harm or death) and whether recalls are still ongoing. Most recalls are Class II/III. "Ongoing" reflects openFDA's last-published status — device recalls often stay marked ongoing long after they're resolved in practice; confirm current status at the FDA.

Most common reasons

This recall is being conducted due to out of specification assay results in a limited number of bottles that were stored 1
Labeling: Label Mix-up: a bag of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection was found inside an overwrap labe 1
Failed Impurities/Degradation Specifications: An out-of-Specification for total related compounds 1
Failed Impurities/Degradation Specifications: Out-of-specification results for total related compounds observed during r 1
The filter included in the carton has an expiration date that has expired prior to the expiration date of the actual pro 1

Recalls

RECORDED — these are the FDA's published recall enforcement records (openFDA). Recalls are listed under the exact firm name as filed; a large manufacturer may also file under name variants, so this may not be the company's complete cross-variant record — confirm at the FDA recall database. This page informs and routes; it is not medical advice or a verdict on the company.

Machine-readable: JSON-LD · Markdown